Summary & Overview

CPT 0164U: ibs–smart™ Blood Test for IBS with Diarrheal Component

CPT code 0164U designates the ibs–smart™ Proprietary Laboratory Analysis from Gemelli Biotech, a blood-based diagnostic that measures anti–CdtB and anti–vinculin antibodies and uses an algorithm to detect irritable bowel syndrome with a diarrheal component or to signal need for further testing. As a PLA code, 0164U applies to a single, manufacturer-specific test and is intended to standardize reporting for this proprietary assay.

This publication examines national payer coverage among major carriers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find summaries of coverage considerations, typical sites of service, and the clinical context underpinning use of the test. The analysis highlights where PLA coding affects claims capture and administrative workflows, plus how payers commonly categorize lab-based diagnostic algorithms.

Audiences will gain concise benchmarks on payer engagement, an explanation of the test’s clinical role in evaluating suspected IBS with diarrhea, and a clear presentation of what information is and is not available for payer policies and utilization. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0164UCPTProprietary Laboratory AnalysisIBS diagnosticserologylaboratory medicinediagnostic algorithmibs-smartbiomarkers

Billing Code Overview

CPT code 0164U is a Proprietary Laboratory Analyses (PLA) code for the ibs–smart™ blood test developed by Gemelli Biotech. The test measures antibodies anti–CdtB and anti–vinculin, two validated biomarkers associated with irritable bowel syndrome (IBS), and applies an algorithm to identify IBS with a diarrheal component or indicate the need for further diagnostic evaluation.

Service Type: Proprietary laboratory diagnostic test (serology with algorithmic interpretation)

Typical Site of Service: Clinical laboratory or outpatient phlebotomy site with laboratory analysis

Clinical & Coding Specifications

Clinical Context

A 34-year-old adult presents to a gastroenterology clinic with a 6‑month history of recurrent abdominal pain, increased stool frequency, and loose stools consistent with a diarrheal pattern. The clinician documents symptoms consistent with irritable bowel syndrome with diarrhea (IBS‑D) after initial history and physical exam and excludes alarm features (weight loss, GI bleeding, family history of IBD/colon cancer). The clinician orders the proprietary blood test 0164U (ibs–smart™ by Gemelli Biotech) to measure anti‑CdtB and anti‑vinculin antibodies and apply the test algorithm to support a diagnosis of IBS with diarrheal component or to indicate need for additional diagnostic evaluation.

Typical clinical workflow:

Patient presents to outpatient gastroenterology or primary care clinic for evaluation of chronic diarrhea and abdominal pain.
Clinician documents symptom history, medication review, and relevant negative alarm signs; obtains basic labs (CBC, CMP) and stool testing as clinically indicated.
If clinical suspicion for post‑infectious IBS or IBS‑D remains, clinician orders 0164U through the clinic’s laboratory ordering system or the proprietary lab vendor.
Venous blood sample is collected in the outpatient phlebotomy area or clinic and sent to the performing laboratory according to the vendor’s handling requirements.
Laboratory performs the proprietary assay measuring anti‑CdtB and anti‑vinculin antibodies and runs the algorithm; a report is returned to the ordering clinician indicating a positive, negative, or indeterminate result and any recommended next steps per the test report.
Clinician integrates the test result with clinical findings to confirm an IBS‑D diagnosis, counsel the patient, and plan management or order further testing if indicated (for example, celiac serologies, colonoscopy if alarm features develop).

Coding Specifications

Modifier	Description	When to Use
`00`	Procedure code change — no longer used for reporting distinct services	Data not applicable for routine use with `0164U` (included for completeness)

22 | Increased procedural services | Use when work required to process or document the test is substantially greater than typical, if payer allows for PLA laboratory reporting with modifier for unusual effort

26 | Professional component | Use when only the professional interpretation/reporting portion of the laboratory test is billed separately and applicable under payer policy

52 | Reduced services | Use when the laboratory performed a reduced portion of the service compared with full test

54 | Surgical care only | Not typically applicable to this laboratory test; included when billing conventions require separation of care phases

55 | Post‑operative management only | Not typically applicable to this laboratory test

62 | Two surgeons | Not applicable to this laboratory test; applicable in surgical encounters

78 | Return to OR for related procedure | Not applicable to this laboratory test

80 | Assistant surgeon | Not applicable to this laboratory test

82 | Assistant surgeon (when qualified resident unavailable) | Not applicable to this laboratory test

AD | Advanced diagnostic imaging modifier (payer‑specific) | Use per payer when reporting advanced diagnostic components if applicable to the reporting or billing policy for proprietary tests

AS | Physician assistant, nurse practitioner, or clinical nurse specialist services | Use when services related to test ordering or specimen collection are furnished by these clinicians and payer accepts modifier

CO | Contractual obligation | Use to indicate charge adjustment due to contractually required discount or write‑off

QK | Medical direction of 2–4 ancillary staff | Use if the ordering or supervising physician qualifies under payer rules for medical direction in specimen collection workflows

TC | Technical component | Use when billing only the technical component of the laboratory test (instrumentation, reagents, technician time) and payable separately

Taxonomy Code	Specialty	Notes
`207RC0000X`	Gastroenterology	Gastroenterologists commonly order `0164U` for evaluation of suspected IBS‑D and post‑infectious IBS

208D00000X | Family Medicine | Primary care physicians may order the test as part of initial evaluation of chronic diarrhea prior to GI referral

207L00000X | Internal Medicine | General internists evaluating chronic GI symptoms order and interpret results to guide management

363LP0800X | Clinical Laboratory | Clinical laboratory specialists perform, validate, and report proprietary PLA tests; responsible for technical and reporting components

261QM0800X | Phlebotomy | Phlebotomists perform specimen collection and handling per vendor instructions

OpenPayer